Fingerprint
Dive into the research topics of 'Long-term follow-up of MCL patients treated with single-agent ibrutinib: Updated safety and efficacy results'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Long-term follow-up of MCL patients treated with single-agent ibrutinib: Updated safety and efficacy results
Michael L. Wang, Kristie A. Blum, Peter Martin, Andre Goy, Rebecca Auer, Brad S. Kahl, Wojciech Jurczak, Ranjana H. Advani, Jorge E. Romaguera, Michael E. Williams, Jacqueline C. Barrientos, Ewa Chmielowska, John Radford, Stephan Stilgenbauer, Martin Dreyling, Wieslaw Wiktor Jedrzejczak, Peter Johnson, Stephen E. Spurgeon, Liang Zhang, Linda Baher
- University of Texas MD Anderson Cancer Center
- Ohio State University Comprehensive Cancer Center
- Hackensack University Medical Center
- Barts Health NHS Trust
- University of Wisconsin Madison
- Jagiellonian University
- Stanford University Medical Center
- Donald and Barbara Zucker School of Medicine at Hofstra/Northwell
- Centrum Onkologii Prof. Franciszka Łukaszczyk
- University Hospital Ulm
- Klinikum der Universitat Munchen ( University of Munich )
- Medical University Of Warsaw
- Oregon Health and Science University
- Pharmacyclics LLC
- University of Plymouth
Research output: Contribution to journal › Article › peer-review